In contrast, tumor-specific major histocompatibility complex class I and II (tsMHCI and tsMHCII) required for immune cell recruitment are significantly repressed in BRAFV600E PTC cells, correlating with reduced lymphocytic infiltration of CD8+ and CD4+ T cells9–11. Here, CD8A is linked to neoplasm.